Butterfly Health Network has raised $250m in funding, led by Fidelity, for its smartphone and tablet-connected ultrasound device, Butterfly IQ, which received FDA approval last fall. Using a cheaply produced semiconductor chip instead of the piezoelectric crystals usually found in ultrasounds, the Butterfly IQ will soon go on the market at the low price of $2,000, far less than the cost of portable ultrasound rivals. Made up from thousands of programmable micro-machined sensors, the chip can mimic the three ultrasonic waves that are needed, producing a high-quality scan at an affordable price. Butterfly's total funding is now $350m.
Butterfly Health Network has raised $250m in funding, led by Fidelity, for its smartphone and tablet-connected ultrasound device, Butterfly IQ, which received FDA approval last autumn. Using a cheaply produced semiconductor chip instead of the piezoelectric crystals usually found in ultrasounds, the Butterfly IQ will soon go on the market at the low price of $2,000, far less than the cost of portable ultrasound rivals. Made up from thousands of programmable micro-machined sensors, the chip can mimic the three ultrasonic waves that are needed, producing a high-quality scan at an affordable price. Butterfly's total funding is now $350m.